Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-12-18

Clinical Trial Update: Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 trial update on the efficacy and safety of IDP-120 Gel for acne vulgaris has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IDP-120 Gel

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED